{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tamoxifen",
  "nciThesaurus": {
    "casRegistry": "10540-29-1",
    "chebiId": "CHEBI:41774",
    "chemicalFormula": "C26H29NO",
    "definition": "An antineoplastic nonsteroidal selective estrogen receptor modulator (SERM).  Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA.  The result is a reduction in DNA synthesis and cellular response to estrogen.  In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth.",
    "fdaUniiCode": "094ZI81Y45",
    "identifier": "C62078",
    "preferredName": "Tamoxifen",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1821",
      "C2089"
    ],
    "synonyms": [
      "1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene",
      "TAMOXIFEN",
      "Tamoxifen",
      "tamoxifen"
    ]
  }
}